(Press-News.org) AUGUSTA, Ga. – One of the first-known oncogenes has a protein partner that helps breast cancer proliferate and when it's blocked, so is the cancer, scientists report.
The gene ErbB2, commonly called HER2, is highly expressed in about 25 percent of breast cancers. Scientists have now found the protein Erbin, thought to be an anti-tumor factor, also is highly expressed in these cancers and essential to ErbB2's support of breast cancer.
When scientists interfere with the interaction between the two in mice, it inhibits tumor development and the usual spread to the lungs, according to an international team reporting in the journal PNAS.
The team documented the overexpression of both in 171 cases of mostly aggressive human breast cancer as well.
The findings point toward a new therapeutic target for aggressive breast cancer and potentially an adjunct for women who become resistant to Herceptin, or trastuzumab, the drug commonly given to ErbB2-positive patients, said Dr. Lin Mei, corresponding author and Chairman of the Department of Neuroscience and Regenerative Medicine at the Medical College of Georgia at Georgia Regents University. Additionally, Erbin could be a diagnostic biomarker that physicians look for in breast tissue biopsies, Mei said.
Erbin, which is also expressed in healthy breast tissue, is critical to the stability and activity of aggressive, ErbB2-positive breast cancer, the research shows.
When the scientists decreased Erbin levels, either by a gene therapy technique that reduced its production or a peptide that interfered with its interaction with ErbB2, breast cancer growth and spread was dramatically reduced or eliminated. "Erbin is an intracellular molecule that binds to ErbB2 and stabilizes it," Mei said. "If you take it out, ErbB2 becomes unstable."
ErbB2, on the other hand, typically extends both outside and inside breast cancer cells. Drugs such as Herceptin degrade excessive levels of the oncogene by targeting the portion that sticks out of the cell, which can be powerfully effective, moving patients from high-risk to a potential cure, Mei said.
"But the tumors are very smart," Mei said. In this case, breast cancer cells can mutate so they no longer have an external protrusion of ErbB2, leaving Herceptin without a place to bind. While getting inside the cells can be more difficult, the ability to target intracellular Erbin could one day make a difference for these patients.
"Erbin itself could be a novel target: you disrupt the interaction, and it will be therapeutic," Mei said. "Secondly, when a patient becomes Herceptin-resistant because the extracellular domain of ErbB2 is lost, this approach should still be effective because of the critical interaction of the two."
Next steps include refinement of the peptide they used for laboratory studies as well as high throughput screenings to look at other existing small molecules that might run important interference.
Mei and his colleague, Dr. Jean-Paul Borg, Director of the Cancer Research Center of Marseille, both came across Erbin in 2001. Neuroscientist Mei was looking for proteins that regulate the protective covering around nerves and Borg was looking for cancer-relevant proteins. It turned out Erbin was involved in both. The current international team also includes scientists from China's Hangzhou Normal University and First Affiliated Hospital and Institute of Life Sciences of Nanchang University.
The Food and Drug Administration approved Herceptin for women with metastatic breast cancer who overexpress ErbB2, or HER2, in 1998 and, in 2006, as an adjuvant treatment in early stage HER2- positive breast cancer.
INFORMATION:
Imagine you're dining out with a friend who insists on sharing some chocolate cake for dessert. Since the decision has already been made for you, you gladly join in without feeling any regret. According to a new study in the Journal of Consumer Research, consumers are happier when someone else decides they can indulge in dessert or other guilty pleasures.
"Most of us don't like being forced to do things. The freedom to make our own decisions generally energizes us and increases our sense of well-being. However, when it comes to purchasing and consuming products normally ...
Consumers worldwide associate France with fashion and luxury and are willing to pay a lot for French luxury products such as perfume and wine. But what about products made in countries with less favorable reputations? A new study in the Journal of Consumer Research shows that consumers won't judge a country's products by its reputation if the products are well-made.
"Positive feelings about a country don't always translate into more favorable opinions of its products. A positive opinion of a country may actually make consumers think more about whether or not the country ...
October 14, 2014 –Adolescents whose parents better understand their daily experiences have better psychological adjustment, suggests a study in the October issue of Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Having parents who understand how their day went may even affect teens' cellular responses to stress—providing a possible link to improved physical health as well. "These results provide ...
It might not be obvious on the scales, but healthy eating and increased physical activity from walking during pregnancy is directly associated with a range of improved outcomes at birth, according to researchers from the University of Adelaide.
Results of the world's biggest study of its kind – offering healthy eating and exercise advice to pregnant women who are overweight or obese – are published today in two papers in the journal BMC Medicine.
"While it might have been expected that healthier eating and increased physical activity during pregnancy would ...
A Rice University study of tamper-resistant voting methods revealed that only 58 percent of ballots were successfully cast across three voting systems. The researchers concluded additional work is needed to make voting both secure and user-friendly.
The study, "Usability of Voter Verifiable, End-to-End Voting Systems: Baseline Data for Helios, Prêt à Voter and Scantegrity II," examined three new end-to-end voting systems – systems that give voters the option to both verify the system is working properly and to check that their votes have been recorded ...
Extreme adaptations of species often cause such significant changes that their evolutionary history is difficult to reconstruct. Zoologists at the University of Basel in Switzerland have now discovered a new parasite species that represents the missing link between fungi and an extreme group of parasites. Researches are now able to understand for the first time the evolution of these parasites, causing disease in humans and animals. The study has been published in the latest issue of the scientific journal Proceedings of the National Academy of Sciences (PNAS).
Parasites ...
Putnam Valley, NY. (Oct. 13, 2014) – Two studies recently published in Cell Transplantation reveal that cell transplantation may be an effective treatment for spinal cord injury (SCI), a major cause of disability and paralysis with no current restorative therapies.
Using laboratory rats modeled with SCI, researchers in Spain found in laboratory tests on cells harvested from rats - specifically ependymal progenitor cells (epSPCs), multipotent stem cells found in adult tissues surrounding the ependymal canal of the spinal cord - responded to a variety of compounds ...
The dirt in your backyard may hold the key to isolating cancerous tumors and to potential new treatments for a host of cancers.
University of Iowa researchers have found a gene in a soil-dwelling amoeba that functions similarly to the main tumor-fighting gene found in humans, called PTEN.
When healthy, PTEN suppresses tumor growth in humans. But the gene is prone to mutate, allowing cancerous cells to multiply and form tumors. PTEN mutations are believed to be involved in 40 percent of breast cancer cases, up to 70 percent of prostate cancer cases, and nearly half of ...
This news release is available in German. In order to invade healthy tissue, tumor cells must leave the actual tumor and enter the bloodstream or lymphatic system. For this purpose, they use certain enzymes, proteases that break down the tissue surrounding the tumor, thus opening the way for tumor cells to reach blood or lymphatic vessels. To keep the proteases in check, the body produces inhibitors such as the protein TIMP-1, which thwart the proteases in their work.
But during development of metastases, the control function of this inhibitor appears not only to ...
HOUSTON – (Oct. 13, 2014) – New research from Rice University's Baker Institute for Public Policy found that states with a large minority population tend to incarcerate more people.
According to lead author Katharine Neill, states with large African-American populations are more likely to have harsher incarceration practices, worse conditions of confinement and tougher policies toward juveniles compared with other states. She said these findings provide some support for long-standing arguments among sociology and criminal justice experts that the criminal ...
